Ann: Complete Regression of TNBC Tumours and Protective Immunity, page-214

  1. 152 Posts.
    lightbulb Created with Sketch. 7
    It's worth noting that tests that are successful in mice may not necessarily be successful in humans (I believe it's approx: 33% translates to human to some degree, 50% it has no effect and 17% it is harmful- please DYOR)

    Nonetheless- successful animal trials are an important and necessary precursor, and a huge leap in the right direction.

    In terms of optimal trading/investment strategies- that's up to the individual. I'm an optimist: if PoC keeps delivering, I expect to take some profits soon after human trials are announced (at least cost out) and ride the rest.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
12.5¢
Change
-0.010(7.41%)
Mkt cap ! $10.59M
Open High Low Value Volume
12.5¢ 12.5¢ 12.5¢ $1.697K 13.57K

Buyers (Bids)

No. Vol. Price($)
2 47096 12.5¢
 

Sellers (Offers)

Price($) Vol. No.
13.0¢ 560 1
View Market Depth
Last trade - 10.41am 17/06/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.